Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study. 2013

Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia. blucic@pharmacy.bg.ac.rs

Series of twelve chalcone and propafenone derivatives has been synthesized and evaluated for anticancer activities against HeLa, Fem-X, PC-3, MCF-7, LS174 and K562 cell lines. The 2D-QSAR and 3D-QSAR studies were performed for all compounds with cytotoxic activities against each cancer cell line. Partial least squares (PLS) regression has been applied for selection of the most relevant molecular descriptors and QSAR models building. Predictive potentials of the created 2D-QSAR and 3D-QSAR models for each cell line were compared, by use of leave-one-out cross-validation and external validation, and optimal QSAR models for each cancer cell line were selected. The QSAR studies have selected the most significant molecular descriptors and pharmacophores of the chalcone and propafenone derivatives and proposed structures of novel chalcone and propafenone derivatives with enhanced anticancer activity on the HeLa, Fem-X, PC-3, MCF-7, LS174 and K562 cells.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
January 2013, Chemical & pharmaceutical bulletin,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
October 2015, Bioorganic & medicinal chemistry letters,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
February 2015, Journal of agricultural and food chemistry,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
November 2016, Chemical biology & drug design,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
December 2021, European journal of medicinal chemistry,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
April 2021, International journal of molecular sciences,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
October 2014, European journal of medicinal chemistry,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
January 2022, Bioorganic & medicinal chemistry letters,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
February 2018, Bioorganic & medicinal chemistry letters,
Branka M Ivković, and Katarina Nikolic, and Bojana B Ilić, and Željko S Žižak, and Radmila B Novaković, and Olivera A Čudina, and Sote M Vladimirov
June 2023, Fitoterapia,
Copied contents to your clipboard!